Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01324895 · ClinicalTrials.gov registry record

Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing

A clinical trial of Small Intestinal Bacterial Overgrowth Syndrome (SIBO) and Small Bowel Bacterial Overgrowth Syndrome (SBBOS), sponsored by University of Florida.

Completed
Registry status
944
Enrollment target
1
Study location

NCT01324895 is a study of Small Intestinal Bacterial Overgrowth Syndrome (SIBO) and Small Bowel Bacterial Overgrowth Syndrome (SBBOS) that has completed, run by University of Florida. The registered enrollment target is 944 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01324895, a study of Small Intestinal Bacterial Overgrowth Syndrome (SIBO) and Small Bowel Bacterial Overgrowth Syndrome (SBBOS), has completed, sponsored by University of Florida.

COMPLETED
Registry status
944 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to compare the efficacy of prokinetics versus antibiotics versus a combination of antibiotics plus prokinetics in the eradication of Small-Intestinal Bacterial Over-Growth Syndrome (SIBO) in those with and without a positive D-xylose Breath Test. Hypothesis: Patients with SIBO treated with a combination of prokinetics and in particular octreotide and antibiotics will have reduced recurrence rates of SIBO than either therapy given alone.

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 944 participants
Start Date 2010-08
Est. Completion 2012-03

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01324895

The ClinicalTrials.gov registry entry for NCT01324895 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 944 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Small Intestinal Bacterial Overgrowth Syndrome (SIBO) appearing as the primary indexed condition, and to 0 interventions.

NCT01324895 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01324895 about?

NCT01324895 is a clinical study titled "Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing". The objective of this study is to compare the efficacy of prokinetics versus antibiotics versus a combination of antibiotics plus prokinetics in the eradication of Small-Intestinal Bacterial Over-Growth Syndrome (SIBO) in those with and without a positive D-xylose Breath Test. Hypothesis: Patients ...

What is the current status of trial NCT01324895?

This trial is currently completed. The enrollment target is 944 participants. The study started on 2010-08. Estimated completion is 2012-03.

What conditions does trial NCT01324895 study?

This clinical trial studies the following conditions: Small Intestinal Bacterial Overgrowth Syndrome (SIBO), Small Bowel Bacterial Overgrowth Syndrome (SBBOS).

Who is sponsoring clinical trial NCT01324895?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01324895 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Small Intestinal Bacterial Overgrowth Syndrome (SIBO)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.